# Ligand Pharmaceuticals Incorporated (LGND)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LGND/charts)

## P/E windows

| Window | Value |
| --- | --- |
| P/E1 | 35.64 |
| P/E2 | 581.66 |
| P/E3 | 139.36 |
| P/E4 | 153.67 |
| P/E5 | 160.10 |
| P/E6 | 150.52 |
| P/E7 | 270.55 |
| P/E8 | 39.58 |
| P/E9 | 41.95 |
| P/E10 | 46.78 |
| P/E11 | 40.35 |
| P/E12 | 43.58 |
| P/E13 | 46.70 |
| P/E14 | 50.29 |
| P/E15 | 53.79 |

Widest P/E window this company has the history to fill: 15 years. Shorter windows are still computed; longer ones are left empty rather than padded.

## Other views

- [Metrics](https://sponda.capital/en/LGND.md)
- [Fundamentals](https://sponda.capital/en/LGND/fundamentals.md)
- [Compare](https://sponda.capital/en/LGND/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.